Actualités Neuphoria Therapeutics Inc - NEUP | Actions NASDAQ | ADVFN

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Neuphoria Therapeutics Inc (NEUP)
Neuphoria Therapeutics Inc (NEUP) Actualités

Neuphoria Therapeutics Inc (NEUP)

4,72

-0,12

(-2,48%)

Fermé 15 Mars 9:00PM

Retardé de 15 minutes

4,70

-0,02

(-0,42%)

Après les heures de négociation: 11:42PM

Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form EFFECT - Notice of Effectiveness

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form S-8 - Securities to be offered to employees in employee benefit plans

Form S-3 - Registration statement under Securities Act of 1933

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Form EFFECT - Notice of Effectiveness

Form EFFECT - Notice of Effectiveness

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Neuphoria Therapeutics

DJ US Exploration and Pr...

Bellerophon Therapeutics

CI WisdomTree ICBCCS S&P...

iShares US Consumer Focu...

FTSEurofirst 300 Eurozon...

DJ Industrial Average Fu...

Bankfirst Capital (QX)

B Riley Financial

FlexShares Global Upstre...

Purpose Gold Bullion

Horizons Global BBIG Tec...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales